Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
  • Ask Questions

Tag: Captisol

February 15, 2021 Drug delivery / Pharma applications

Reviews on remdesivir in Covid-19 treatment

Remdesivir (GS-5734; Gilead Sciences Inc., US) is an investigational nucleoside analog that acts as a competitive inhibitor of viral RNAdependent

Continue reading

February 8, 2021 Drug delivery / Pharma applications

Renal and liver injury following the treatment of covid-19 by remdesivir

Remdesivir initially was intravenously administrated to treat the Ebola disease however right now it has been administered to treat COVID-19

Continue reading

January 11, 2021 Drug delivery / Pharma applications

Sedor Pharmaceuticals Receives FDA Approval for SESQUIENT™ (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients

Sedor Pharmaceuticals, LLC (Sedor) announced on November 9, 2020 that the U.S. Food and Drug Administration (FDA) has approved SESQUIENT

Continue reading

January 7, 2021 Drug delivery / Pharma applications

Remdesivir dry powder inhalation formulation, pharmacokinetic study in hamsters

Currently, remdesivir is only available as a lyophilized powder for reconstitution and intravenous53 infusion and concentrate solution for dilution and

Continue reading

January 6, 2021 Non-pharma applications / Other industrial use / Uncategorized

Use of sulfobutylether beta cyclodextrin for preparing ceramics

A very few patent applications may trace back prior art disclosure to the Neolithic Age (from 10000 – 4500 BC)

Continue reading

December 11, 2020 Drug delivery / Pharma applications

Marinus Pharmaceuticals Provides SBECD-enabled Ganaxolone Clinical Data

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced it

Continue reading

December 11, 2020 Drug delivery / Pharma applications

Top-line final data from CD-enabled Cantrixil Phase I study confirms prior positive efficacy and safety signals

Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company shared top-line final data from its phase I study of Cantrixil (TRX-E-002-1)

Continue reading

November 9, 2020 Drug delivery / Pharma applications

Sedor Pharmaceuticals Receives FDA Approval for SESQUIENT™ (SBECD-enabled fosphenytoin)

Ligand Pharmaceuticals Incorporated announced that its partner Sedor Pharmaceuticals, LLC has received approval from the U.S. Food and Drug Administration

Continue reading

October 23, 2020 Drug delivery / Pharma applications

Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing

Remdesivir, an investigational broad-spectrum antiviral agent, formulated with sulfobutyl beta-cyclodextrin, has shown in vitro activity against SARSCoV-2. Currently, remdesivir is

Continue reading

October 14, 2020 Drug delivery / Pharma applications

Combined therapy (remdesivir, dexamethasone and monoclonal antibodies) for the treatment of President Trump

Science News reported on October 5, 2020 the opinion of Rajesh Gandhi, an infectious diseases physician at Massachusetts General Hospital

Continue reading

Posts navigation

1 2 3 … 6 Next Posts»

Recent Posts

  • BIO-Europe Spring® Digital
  • HPBCD is a unique component in Janssen’s COVID-19 vaccine candidate
  • Effect of buffers on the stability of SBECD complexes
  • Solution Density Models as Functions of Sodium Chloride, HPBCD, and temperature
  • New approach in ocular drug delivery: cyclodextrin-containing mucoadhesive eye drop formulations

Tags

antiviral Betadex Sulfobutyl Ether Sodium Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems Drugs FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease Polymer remdesivir SBECD Special issue Synthesis Trappsol

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (8)
  • Analysis (12)
  • CD as API (99)
  • CD derivatives (124)
  • Cosmetics and toilettry (10)
  • Drug delivery (191)
  • E-ducation (41)
  • Environmental (41)
  • Events (98)
  • Food (57)
  • Gene delivery (6)
  • In Hungarian (4)
  • Non-pharma applications (97)
  • Other industrial use (34)
  • Pharma applications (351)
  • Supramolecular systems (7)
  • Uncategorized (23)

Top Posts

  • HPBCD is a unique component in Janssen's COVID-19 vaccine candidate
  • Effect of buffers on the stability of SBECD complexes
  • BIO-Europe Spring® Digital
  • New approach in ocular drug delivery: cyclodextrin-containing mucoadhesive eye drop formulations
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • The use of β-CDs to improve honey bee health
  • Solution Density Models as Functions of Sodium Chloride, HPBCD, and temperature
  • Cochlear spiral ganglion neuron degeneration following cyclodextrin-induced hearing loss
  • Oculis aces the Phase 2 clinical trial for OCS-01 treating DME
  • Cyclo Therapeutics Announces Positive Efficacy Data in Patients with Niemann-Pick Disease Type C

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 289 other subscribers